抗炎症治療薬の世界市場 2024-2028

抗炎症治療薬市場は2023-2028年に387億米ドル、予測期間中のCAGRは6.3%で成長すると予測されます。

当レポートでは、抗炎症治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。適応外使用の増加、RAに対するより安全な生物学的製剤へのアンメットニーズ、改善された診断方法の利用可能性などが市場を牽引しています。

本調査では、新規抗炎症薬の出現が今後数年間の抗炎症治療薬市場成長を牽引する主要因の1つであるとしています。また、RA治療における遺伝子治療の利用やtnfα阻害剤による市場の支配は、市場の大きな需要につながると思われます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 世界の抗炎症治療薬市場 2018-2022
• 用途別セグメント分析 2018-2022
• 薬物クラス別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：用途別

• 市場セグメンテーション
• 比較：用途別
• RA：市場規模と予測 2023-2028
• 乾癬：市場規模と予測 2023-2028
• MS：市場規模と予測 2023-2028
• 市場機会：用途別

第7章 市場セグメンテーション：薬剤クラス別

• 市場セグメンテーション
• 比較：薬剤クラス別
• 抗炎症生物製剤：市場規模と予測 2023-2028
• コルチコステロイド：市場規模と予測 2023-2028
• NSAIDs：市場規模と予測 2023-2028
• 市場機会：薬剤クラス別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 市場機会：地域別

第10章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第11章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第12章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• AbbVie Inc.
• Alvogen Iceland ehf
• Amgen Inc.
• Amneal Pharmaceuticals Inc.
• Bayer AG
• Bristol Myers Squibb Co.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Ferring BV
• GlaxoSmithKline Plc
• Johnson and Johnson Services Inc.
• Novartis AG
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Parent Market
• Exhibits11: Data Table on - Parent Market
• Exhibits12: Market characteristics analysis
• Exhibits13: Value Chain Analysis
• Exhibits14: Offerings of companies included in the market definition
• Exhibits15: Market segments
• Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits20: Historic Market Size - Data Table on Global Anti-Inflammatory Therapeutics Market 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
• Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits25: Five forces analysis - Comparison between 2023 and 2028
• Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits31: Chart on Market condition - Five forces 2023 and 2028
• Exhibits32: Chart on Application - Market share 2023-2028 (%)
• Exhibits33: Data Table on Application - Market share 2023-2028 (%)
• Exhibits34: Chart on Comparison by Application
• Exhibits35: Data Table on Comparison by Application
• Exhibits36: Chart on RA - Market size and forecast 2023-2028 ($ billion)
• Exhibits37: Data Table on RA - Market size and forecast 2023-2028 ($ billion)
• Exhibits38: Chart on RA - Year-over-year growth 2023-2028 (%)
• Exhibits39: Data Table on RA - Year-over-year growth 2023-2028 (%)
• Exhibits40: Chart on Psoriasis - Market size and forecast 2023-2028 ($ billion)
• Exhibits41: Data Table on Psoriasis - Market size and forecast 2023-2028 ($ billion)
• Exhibits42: Chart on Psoriasis - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on Psoriasis - Year-over-year growth 2023-2028 (%)
• Exhibits44: Chart on MS - Market size and forecast 2023-2028 ($ billion)
• Exhibits45: Data Table on MS - Market size and forecast 2023-2028 ($ billion)
• Exhibits46: Chart on MS - Year-over-year growth 2023-2028 (%)
• Exhibits47: Data Table on MS - Year-over-year growth 2023-2028 (%)
• Exhibits48: Market opportunity by Application ($ billion)
• Exhibits49: Data Table on Market opportunity by Application ($ billion)
• Exhibits50: Chart on Drug Class - Market share 2023-2028 (%)
• Exhibits51: Data Table on Drug Class - Market share 2023-2028 (%)
• Exhibits52: Chart on Comparison by Drug Class
• Exhibits53: Data Table on Comparison by Drug Class
• Exhibits54: Chart on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
• Exhibits55: Data Table on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
• Exhibits56: Chart on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
• Exhibits57: Data Table on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
• Exhibits58: Chart on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
• Exhibits59: Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
• Exhibits60: Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
• Exhibits61: Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)
• Exhibits62: Chart on NSAIDs - Market size and forecast 2023-2028 ($ billion)
• Exhibits63: Data Table on NSAIDs - Market size and forecast 2023-2028 ($ billion)
• Exhibits64: Chart on NSAIDs - Year-over-year growth 2023-2028 (%)
• Exhibits65: Data Table on NSAIDs - Year-over-year growth 2023-2028 (%)
• Exhibits66: Market opportunity by Drug Class ($ billion)
• Exhibits67: Data Table on Market opportunity by Drug Class ($ billion)
• Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits69: Chart on Market share By Geographical Landscape2023-2028 (%)
• Exhibits70: Data Table on Market share By Geographical Landscape2023-2028 (%)
• Exhibits71: Chart on Geographic comparison
• Exhibits72: Data Table on Geographic comparison
• Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits101: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibits102: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibits103: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits109: Market opportunity By Geographical Landscape($ billion)
• Exhibits110: Data Tables on Market opportunity By Geographical Landscape($ billion)
• Exhibits111: Impact of drivers and challenges in 2023 and 2028
• Exhibits112: Overview on criticality of inputs and factors of differentiation
• Exhibits113: Overview on factors of disruption
• Exhibits114: Impact of key risks on business
• Exhibits115: Companies covered
• Exhibits116: Matrix on companies position and classification
• Exhibits117: AbbVie Inc. - Overview
• Exhibits118: AbbVie Inc. - Product / Service
• Exhibits119: AbbVie Inc. - Key news
• Exhibits120: AbbVie Inc. - Key offerings
• Exhibits121: Alvogen Iceland ehf - Overview
• Exhibits122: Alvogen Iceland ehf - Product / Service
• Exhibits123: Alvogen Iceland ehf - Key offerings
• Exhibits124: Amgen Inc. - Overview
• Exhibits125: Amgen Inc. - Product / Service
• Exhibits126: Amgen Inc. - Key offerings
• Exhibits127: Amneal Pharmaceuticals Inc. - Overview
• Exhibits128: Amneal Pharmaceuticals Inc. - Business segments
• Exhibits129: Amneal Pharmaceuticals Inc. - Key news
• Exhibits130: Amneal Pharmaceuticals Inc. - Key offerings
• Exhibits131: Amneal Pharmaceuticals Inc. - Segment focus
• Exhibits132: Bayer AG - Overview
• Exhibits133: Bayer AG - Business segments
• Exhibits134: Bayer AG - Key news
• Exhibits135: Bayer AG - Key offerings
• Exhibits136: Bayer AG - Segment focus
• Exhibits137: Bristol Myers Squibb Co. - Overview
• Exhibits138: Bristol Myers Squibb Co. - Product / Service
• Exhibits139: Bristol Myers Squibb Co. - Key news
• Exhibits140: Bristol Myers Squibb Co. - Key offerings
• Exhibits141: Eli Lilly and Co. - Overview
• Exhibits142: Eli Lilly and Co. - Product / Service
• Exhibits143: Eli Lilly and Co. - Key news
• Exhibits144: Eli Lilly and Co. - Key offerings
• Exhibits145: F. Hoffmann-La Roche Ltd. - Overview
• Exhibits146: F. Hoffmann-La Roche Ltd. - Product / Service
• Exhibits147: F. Hoffmann-La Roche Ltd. - Key offerings
• Exhibits148: Ferring BV - Overview
• Exhibits149: Ferring BV - Product / Service
• Exhibits150: Ferring BV - Key offerings
• Exhibits151: GlaxoSmithKline Plc - Overview
• Exhibits152: GlaxoSmithKline Plc - Business segments
• Exhibits153: GlaxoSmithKline Plc - Key news
• Exhibits154: GlaxoSmithKline Plc - Key offerings
• Exhibits155: GlaxoSmithKline Plc - Segment focus
• Exhibits156: Johnson and Johnson Services Inc. - Overview
• Exhibits157: Johnson and Johnson Services Inc. - Business segments
• Exhibits158: Johnson and Johnson Services Inc. - Key news
• Exhibits159: Johnson and Johnson Services Inc. - Key offerings
• Exhibits160: Johnson and Johnson Services Inc. - Segment focus
• Exhibits161: Novartis AG - Overview
• Exhibits162: Novartis AG - Business segments
• Exhibits163: Novartis AG - Key news
• Exhibits164: Novartis AG - Key offerings
• Exhibits165: Novartis AG - Segment focus
• Exhibits166: Pfizer Inc. - Overview
• Exhibits167: Pfizer Inc. - Product / Service
• Exhibits168: Pfizer Inc. - Key news
• Exhibits169: Pfizer Inc. - Key offerings
• Exhibits170: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits171: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits172: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits173: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits174: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits175: Viatris Inc. - Overview
• Exhibits176: Viatris Inc. - Business segments
• Exhibits177: Viatris Inc. - Key news
• Exhibits178: Viatris Inc. - Key offerings
• Exhibits179: Viatris Inc. - Segment focus
• Exhibits180: Inclusions checklist
• Exhibits181: Exclusions checklist
• Exhibits182: Currency conversion rates for US$
• Exhibits183: Research methodology
• Exhibits184: Information sources
• Exhibits185: Data validation
• Exhibits186: Validation techniques employed for market sizing
• Exhibits187: Data synthesis
• Exhibits188: 360 degree market analysis
• Exhibits189: List of abbreviations

The anti-inflammatory therapeutics market is forecasted to grow by USD 38.7 bn during 2023-2028, accelerating at a CAGR of 6.3% during the forecast period. The report on the anti-inflammatory therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in off-label use, unmet needs for safer biologics for RA, and availability of improved diagnostic modalities.

Technavio's anti-inflammatory therapeutics market is segmented as below:

By Application

• RA
• Psoriasis
• MS

By Drug Class

• Anti-inflammatory biologicals
• Corticosteroids
• NSAIDs

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the emergence of novel anti-inflammatory drugs as one of the prime reasons driving the anti-inflammatory therapeutics market growth during the next few years. Also, use of gene therapy for RA treatment and market dominance by tnf-alpha inhibitors will lead to sizable demand in the market.

The report on the anti-inflammatory therapeutics market covers the following areas:

• Anti-inflammatory therapeutics market sizing
• Anti-inflammatory therapeutics market forecast
• Anti-inflammatory therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-inflammatory therapeutics market vendors that include AbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., Cipla Inc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Ferring BV, GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Lupin Ltd., Viatris Inc., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Novartis AG. Also, the anti-inflammatory therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Drug Class
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Anti-Inflammatory Therapeutics Market 2018 - 2022
  • Historic Market Size - Data Table on Global Anti-Inflammatory Therapeutics Market 2018 - 2022 ($ billion)
• 4.2 Application segment analysis 2018 - 2022
  • Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• 4.3 Drug Class segment analysis 2018 - 2022
  • Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

• 6.1 Market segments
  • Chart on Application - Market share 2023-2028 (%)
  • Data Table on Application - Market share 2023-2028 (%)
• 6.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 6.3 RA - Market size and forecast 2023-2028
  • Chart on RA - Market size and forecast 2023-2028 ($ billion)
  • Data Table on RA - Market size and forecast 2023-2028 ($ billion)
  • Chart on RA - Year-over-year growth 2023-2028 (%)
  • Data Table on RA - Year-over-year growth 2023-2028 (%)
• 6.4 Psoriasis - Market size and forecast 2023-2028
  • Chart on Psoriasis - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Psoriasis - Market size and forecast 2023-2028 ($ billion)
  • Chart on Psoriasis - Year-over-year growth 2023-2028 (%)
  • Data Table on Psoriasis - Year-over-year growth 2023-2028 (%)
• 6.5 MS - Market size and forecast 2023-2028
  • Chart on MS - Market size and forecast 2023-2028 ($ billion)
  • Data Table on MS - Market size and forecast 2023-2028 ($ billion)
  • Chart on MS - Year-over-year growth 2023-2028 (%)
  • Data Table on MS - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Application
  • Market opportunity by Application ($ billion)
  • Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by Drug Class

• 7.1 Market segments
  • Chart on Drug Class - Market share 2023-2028 (%)
  • Data Table on Drug Class - Market share 2023-2028 (%)
• 7.2 Comparison by Drug Class
  • Chart on Comparison by Drug Class
  • Data Table on Comparison by Drug Class
• 7.3 Anti-inflammatory biologicals - Market size and forecast 2023-2028
  • Chart on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
  • Chart on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
  • Data Table on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
• 7.4 Corticosteroids - Market size and forecast 2023-2028
  • Chart on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
  • Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
  • Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)
• 7.5 NSAIDs - Market size and forecast 2023-2028
  • Chart on NSAIDs - Market size and forecast 2023-2028 ($ billion)
  • Data Table on NSAIDs - Market size and forecast 2023-2028 ($ billion)
  • Chart on NSAIDs - Year-over-year growth 2023-2028 (%)
  • Data Table on NSAIDs - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Drug Class
  • Market opportunity by Drug Class ($ billion)
  • Data Table on Market opportunity by Drug Class ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape2023-2028 (%)
  • Data Table on Market share By Geographical Landscape2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity by geography
  • Market opportunity By Geographical Landscape($ billion)
  • Data Tables on Market opportunity By Geographical Landscape($ billion)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
• 12.4 Alvogen Iceland ehf
  • Alvogen Iceland ehf - Overview
  • Alvogen Iceland ehf - Product / Service
  • Alvogen Iceland ehf - Key offerings
• 12.5 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key offerings
• 12.6 Amneal Pharmaceuticals Inc.
  • Amneal Pharmaceuticals Inc. - Overview
  • Amneal Pharmaceuticals Inc. - Business segments
  • Amneal Pharmaceuticals Inc. - Key news
  • Amneal Pharmaceuticals Inc. - Key offerings
  • Amneal Pharmaceuticals Inc. - Segment focus
• 12.7 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
• 12.8 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
• 12.9 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key news
  • Eli Lilly and Co. - Key offerings
• 12.10 F. Hoffmann-La Roche Ltd.
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Product / Service
  • F. Hoffmann-La Roche Ltd. - Key offerings
• 12.11 Ferring BV
  • Ferring BV - Overview
  • Ferring BV - Product / Service
  • Ferring BV - Key offerings
• 12.12 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
• 12.13 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
• 12.14 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
• 12.15 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
• 12.16 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Viatris Inc.
  • Viatris Inc. - Overview
  • Viatris Inc. - Business segments
  • Viatris Inc. - Key news
  • Viatris Inc. - Key offerings
  • Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations